The Prevalence of SIRS following intrarectal Povidone-Iodine and Xylocaine transrectal ultrasound guided prostate biopsy in Rajavithi hospital
Keywords:
Transrectal ultrasoundguided biopsy, TRUS, intrarectal Povidone-Iodine and Xylocaine, infectionAbstract
Objective: To evaluate the prevalence of SIRS following intrarectal Povidone-Iodine and Xylocaine transrectal ultrasound-guided prostate biopsy in Rajavithi hospital.
Material and Method: The data was collected from the operative record for patient who undergoing transrectal ultrasound-guided prostate biopsy in Rajavithi hospital from 1st April 2014 to 30th September 2018. The medical recorders were inspected from the operative date to the appointment date for collect
data including age, body weight, height, underlying disease, serum PSA, SIRS, complication during admission and length of stay.
Result: From 637 males, the SIRS after intrarectal Povidone-Iodine and Xylocaine transrectal ultrasound-guided prostate biopsy was found in 6 patients and all of 6 patients had infection (0.9% of all patient). The patients who have higher BMI have greater risk for developed SIRS (24.98+3.75 vs 23.35+3.49 [p=0.258]). The most common organism in this study is E. coli (hemoculture 1 specimen, urine culture 2 specimens).
Conclusion: The patient preparation of transrectal ultrasound-guided prostate biopsy with intrarectal Povidone-Iodine and Xylocaine may be one of the methods that can reduce SIRS and infection rate from TRUS Bx of the prostate.
References
W. Imsamran, P. Adisai, S. Pongsatorn, C. Isara, N. Kriangkrai, W. Metee, K. Suwanrungrung, S. Sangrajrang, R. Buasom. Cancer in Thailand Vol. IX 2013-2015, Bangkok, 20151.
Benson MC, Olsson CA. Prostate specific antigen and prostate specificantigen density: roles in patient evaluation and management. Cancer 1994;74:1667-1673.
Rovner ES, Schanne FJ, Malkowicz SB, Wein AJ. Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies. J Urol 1997;158:138-141.
Bjurlin MA, Carter HB, Schellhammer P, et al. Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing. J Urol 2013;189:2039-2046.
Jan Krzysztof Rudzinski, Jun Kawakami, FRCSC:Incidence of infectious complications following transrectal ultrasound-guided prostate biopsy in Calgary, Alberta, Canada: A retrospective population-based analysis, Can UrolAssoc J 2014;8:e301-305.
Gil-VernetSedo JM, Alvarez-VijandeGarcía R. Effect of intrarectalpovidone-iodine in the incidence of infectious complications after transrectalprostatic biopsy. Arch Esp Urol 2012; 65:463-466.
De Nunzio C, Lombardo R, Presicce F, Bellangino M, Finazzi Agro E, Gambrosier MB, Trucchi A, Petta S, Tubaro A. Transrectal-ultrasound prostatic biopsy preparation: rectal enema vs. mechanical bowel preparation. Cent European J Urol 2015;68:223-228.
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus
Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-1655.
Kumar A, Griwan MS, Singh SK, Sen J, Pawar DS. Is periprostatic nerve block a gold standard in case of transrectal ultrasound-guided prostate biopsy? Urol Ann 2013;5:152-156.
Kaye KW. Prostate biopsy using automatic gun. Technique for determination of precise biopsy site. Urology 1989;34:111-112.
Grummet J. How to Biopsy: Transperineal Versus Transrectal, Saturation Versus Targeted, What's the Evidence? Urol Clin North Am 2017;44:525-534.
Kam SC, Choi SM, Yoon S, Choi JH, Lee SH, Hwa JS, Chung KH, Hyun JS. Complications of transrectal ultrasound-guided prostate biopsy: impact of prebiopsy enema. Korean J Urol 2014;55:732-736.
Yildirim ME, Badem H, Cavis M, Karatas OF, Cimentepe E, Unal D, Incebay IB. The comparison of the influence between two different bowel preparation methods on sepsis after prostate biopsies. Cent European J Urol 2015;68:91-94. doi:10.5173/ceju.2015.01.424.
Zhang XH, Jia Y, Guo WH, Ma YR, Yang J, Zhang Y, Hou SC, Zhang CC. Clinical comparison of the efficacy of three different bowel preparation methods on the infectious complications following transrectal ultrasonography-guided prostate biopsy in nursing practice. J Clin Nurs 2018;27:2583-2589.
Pu C, Bai Y, Yuan H, Li J, Tang Y, Wang J, Wei Q, Han P. Reducing the risk of infection for transrectal prostate biopsy with povidone-iodine: a systematic review and meta-analysis. Int Urol Nephrol 2014;46:1691-1698.
Goh YS, Law ZW, Tiong HY. Re: A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy: Z. AbuGhosh, J. Margolick, S. L. Goldenberg,
S. A. Taylor, K. Afshar, R. Bell, D. Lange, W. R. Bowie, D. Roscoe, L. Machan and P. C. Black J Urol 2013; 189: 1326-1331. J Urol 2013;190:2309-2310.
Park DS, Oh JJ, Lee JH, Jang WK, Hong YK, Hong SK. Simple use of the suppository type povidoneiodine
can prevent infectious complications in transrectal ultrasound-guided prostate biopsy. Adv Urol 2009:750598. doi:10.1155/2009/750598
